Compositions for nasal drug delivery, methods of making same, and methods of removing residual solvent from pharmaceutical preparations
The present invention relates to pharmaceutical compositions for delivery of drugs intended to reside in the nose, compositions for nasal administration of drugs, e.g., antiviral agents, and particularly antiviral agents comprising the human major rhinovirus receptor, also known as intercellular adhesion molecule-1 (ICAM-1); to methods of making said nasal drug compositions, and to an improved process for the removal of residual solvent from pharmaceutical matrices.
Bayer Corporation
C A A A Y
C07K A61K A61K A61K Y10T
inventional inventional inventional additional additional
Kris P. Rajiv Michael A. Neville M. Wei Margaret
Antonsen Nayar Shearer Concessio Wang Caudle